SHANA MEGHAN WEBB
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Acute Care PANAMA CITY, FL NPI 1730639725
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Acute Care FL Fresenius USA Marketing, Inc. All categories
General Payments — all program years on this page
$2,756.82
- Category: General Payments
- Program years: PY2021–2024
- Record count: 62
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $284.81 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $260.20 | 7 |
| Education | $24.61 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Fresenius USA Marketing, Inc. | $131.42 | 5 |
| Acerta Pharma LLC | $128.78 | 2 |
| AKEBIA THERAPEUTICS INC | $24.61 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1104676841 | AstraZeneca Pharmaceuticals LP | $14.26 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105561234 | AstraZeneca Pharmaceuticals LP | $114.52 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1145833897 | AKEBIA THERAPEUTICS INC | $24.61 | 10/24/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1154194712 | Fresenius USA Marketing, Inc. | $1.68 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1154194714 | Fresenius USA Marketing, Inc. | $18.25 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1154194716 | Fresenius USA Marketing, Inc. | $18.50 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1154194718 | Fresenius USA Marketing, Inc. | $27.04 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1154194720 | Fresenius USA Marketing, Inc. | $65.95 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.